drugset / Trial / NCT00417937

A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily

NCT00417937

Phase 4 Completed 98 enrolled LEO Pharma Bayer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy and tolerability of azelaic acid 15% gel applied once daily versus twice daily in the treatment of patients with papulopustular rosacea.

Timeline

Start
2007-01
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelaic acid Small molecule 15 % Topical

Indications